Skip to main content

Biopharma Startups

Updated July 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 854 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
854
Total Funding
$1.9B
Avg Funding
$75.2M
Global Reach
8
countries

Top Cities for Biopharma

Nijmegen
Munich
West Nyack
Raleigh
Seattle
Minneapolis

Recently Funded Companies

Export
Nijmegen, The Netherlands

Protinhi Therapeutics is a preclinical stage biotech company developing antivirals against viral threats.

$2.5M raised
Oct 2022

Founder Contacts

30,000+ verified contacts

Munich, Germany

iOmx Therapeutics focuses on the development of cancer immunotherapy treatments.

$75.4M raised
Oct 2021

Founder Contacts

30,000+ verified contacts

West Nyack, United States

IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune diseases.

$10.0M raised
Oct 2021

Founder Contacts

30,000+ verified contacts

Raleigh, United States

Marius Pharmaceuticals is a biopharmaceutical company that brings novel treatments to a range of diseases with unmet medical needs.

$6.0M raised
Oct 2021

Founder Contacts

30,000+ verified contacts

Seattle, United States

HDT Bio is a developer of RNA vaccines and therapeutics based on LION formulation technology.

$1.0M raised
Oct 2023

Founder Contacts

30,000+ verified contacts

Minneapolis, United States

Vergent Bioscience is a biotech company focusing on the development of tumor-targeted molecular imaging molecules for cancer surgery.

$21.5M raised
Oct 2022

Founder Contacts

30,000+ verified contacts

Castroville, United States

Biopharmaceutical Research Company develops active pharmaceutical ingredients for plant therapeutics.

$20.0M raised
Oct 2022

Founder Contacts

30,000+ verified contacts

Oxford, United Kingdom

Ervaxx is illuminating the immune interface to develop new cancer therapies.

$32.5M raised
Oct 2024

Founder Contacts

30,000+ verified contacts

Norwalk, United States

Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.

$4.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Wilmington, United States

Ergo Bioscience is a biotech company that creates and reproduces organoleptically identical products from animals.

Oct 2024

Founder Contacts

30,000+ verified contacts

Hayward, United States

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

$250.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Miami, United States

Veru is a biopharmaceutical company that specializes in developing novel medicines.

$25.2M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Plymouth Meeting, United States

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

$248.0M raised
Oct 2024

Founder Contacts

30,000+ verified contacts

Rouen, France

Aurora Cold Plasma Sterilisation provides low temperature plasma sterilator for medical and research purposes.

Oct 2023

Founder Contacts

30,000+ verified contacts

Chapel Hill, United States

iOrganBio is a pioneering cell production platform.

$2.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

La Jolla, United States

Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.

$825.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.

$3.6M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Los Angeles, United States

Rarity is a biotechnology company that offers genetic treatments for immune diseases.

$4.6M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and prevent autoimmune diseases.

$80.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Solna, Sweden

Cellcolabs is a biotechnology company that production of mesenchymal stromal cells for research and clinical applications.

$12.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Houston, United States

Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.

$8.0M raised
Oct 2022

Founder Contacts

30,000+ verified contacts

Rome, Italy

Bioprocesses and bioreactors

$830K raised
Oct 2022

Founder Contacts

30,000+ verified contacts

Columbus, United States

Vitranu develops novel extended administration drug delivery technology.

$1.5M raised
Oct 2021

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.

$245.0M raised
Oct 2023

Founder Contacts

30,000+ verified contacts

Copenhagen, Denmark

Henlez provides biologic solutions to manage recurrent and follicular skin disorders.

$988K raised
Oct 2022

Founder Contacts

30,000+ verified contacts

Showing 801 to 825 of 854 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 854 biopharma companies tracked in the VCBacked database.

Average Funding
$75.2M
Total Funding Tracked
$1.9B
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Cambridge
2 companies$83.6M
2.Nijmegen
1 companies$2.5M
3.Munich
1 companies$75.4M
4.West Nyack
1 companies$10.0M
5.Raleigh
1 companies$6.0M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

854 Biopharma Startups (2026) — Recently Funded Companies, Investors & Rounds — Page 33 | VCBacked